• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[中国浆细胞白血病患病率调查:基于2016年全国城镇医疗保险的计算]

[Prevalence investigation of plasma cell leukemia in China: a calculation based on national urban medical insurance in 2016].

作者信息

Xu L, Liu Y, Lai X F, Bai Y, Feng J N, Zhan S Y, Huang X J, Wang S F, Lu J

机构信息

Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.

Peking University Institute of Hematology, Peking University People's Hospital, National Clinical Research, Center for Hematologic Disease, Beijing 100044, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2020 Dec 14;41(12):984-988. doi: 10.3760/cma.j.issn.0253-2727.2020.12.003.

DOI:10.3760/cma.j.issn.0253-2727.2020.12.003
PMID:33445844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7840543/
Abstract

To analyze the epidemiological features of patients with plasma cell leukemia (PCL) and calculate the prevalence of PCL in urban China in 2016. Calculation in this study was based on China's urban basic medical insurance from 23 provinces between January 1, 2016 and December 31, 2016. The identification of the patients with PCL was based on the disease names and codes in the claim data. Subgroup analyses were carried out by sex, region, and age. To test the robustness of the results, we performed sensitivity analyses. Age-adjusted prevalence was calculated, based on the 2010 Chinese census data. The prevalence of PCL in urban China in 2016 was 0.11 per 100 000 population (95% 0.05-0.19) , and the male prevalence and female prevalence were 0.12 per 100 000 population (95% 0.06-0.21) and 0.10 per 100 000 population (95% 0.04-0.19) , respectively. The prevalence of PCL peaked at 70-79 years old. Sensitivity analyses proved the robustness of the primary result. The age-adjusted prevalence based on 2010 Chinese census data was 0.12 per 100 000 population (95% 0.11-0.13) . This study firstly analyzed the epidemiological characteristics of PCL in China, which can provide evidence for the research and policies regarding PCL.

摘要

分析浆细胞白血病(PCL)患者的流行病学特征,并计算2016年中国城市地区PCL的患病率。本研究的计算基于2016年1月1日至2016年12月31日期间23个省份的中国城市基本医疗保险数据。PCL患者的识别基于理赔数据中的疾病名称和编码。按性别、地区和年龄进行亚组分析。为检验结果的稳健性,我们进行了敏感性分析。根据2010年中国人口普查数据计算年龄调整患病率。2016年中国城市地区PCL的患病率为每10万人口0.11(95%可信区间0.05 - 0.19),男性患病率和女性患病率分别为每10万人口0.12(95%可信区间0.06 - 0.21)和每10万人口0.10(95%可信区间0.04 - 0.19)。PCL患病率在70 - 79岁达到峰值。敏感性分析证明了主要结果的稳健性。基于2010年中国人口普查数据的年龄调整患病率为每10万人口0.12(95%可信区间0.11 - 0.13)。本研究首次分析了中国PCL的流行病学特征,可为PCL的研究和政策提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b6/7840543/d63f010ed719/cjh-41-12-984-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b6/7840543/d63f010ed719/cjh-41-12-984-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b6/7840543/d63f010ed719/cjh-41-12-984-g001.jpg

相似文献

1
[Prevalence investigation of plasma cell leukemia in China: a calculation based on national urban medical insurance in 2016].[中国浆细胞白血病患病率调查:基于2016年全国城镇医疗保险的计算]
Zhonghua Xue Ye Xue Za Zhi. 2020 Dec 14;41(12):984-988. doi: 10.3760/cma.j.issn.0253-2727.2020.12.003.
2
[Prevalence investigation of solitary plasmacytoma in China: A calculation based on national urban medical insurance in 2016].中国孤立性浆细胞瘤患病率调查:基于2016年全国城镇医疗保险的计算
Zhonghua Xue Ye Xue Za Zhi. 2020 Jun 14;41(6):451-455. doi: 10.3760/cma.j.issn.0253-2727.2020.06.003.
3
[Calculation of the prevalence of progressive muscular atrophy among adults in China based on urban medical insurance data from 15 provinces].基于15个省份城镇医疗保险数据计算中国成年人进行性肌萎缩患病率
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Jun 18;52(3):521-526. doi: 10.19723/j.issn.1671-167X.2020.03.019.
4
[Epidemioloical characteristics and economic burden analysis of palmoplantar pustulosis in urban areas of China].[中国城市地区掌跖脓疱病的流行病学特征及经济负担分析]
Zhonghua Yu Fang Yi Xue Za Zhi. 2024 May 6;58(5):642-648. doi: 10.3760/cma.j.cn112150-20230814-00089.
5
[Epidemiological study of bone and joint injury based on urban medical insurance database].基于城市医疗保险数据库的骨与关节损伤流行病学研究
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Jun 18;52(3):527-534. doi: 10.19723/j.issn.1671-167X.2020.03.020.
6
Urban prevalence of multiple sclerosis in China: A population-based study in six provinces.中国城市多发性硬化症的流行情况:六省基于人群的研究。
Eur J Neurol. 2021 May;28(5):1636-1644. doi: 10.1111/ene.14764. Epub 2021 Feb 23.
7
Prevalence of mammary Paget's disease in urban China in 2016.2016 年中国城市中乳腺派杰氏病的流行情况。
Sci Rep. 2021 Jan 28;11(1):2572. doi: 10.1038/s41598-021-82146-y.
8
Incidence and prevalence of amyotrophic lateral sclerosis in urban China: a national population-based study.中国城市人群肌萎缩侧索硬化症的发病率和患病率:一项全国性基于人群的研究。
J Neurol Neurosurg Psychiatry. 2020 May;91(5):520-525. doi: 10.1136/jnnp-2019-322317. Epub 2020 Mar 5.
9
Medical Insurance Information Systems in China: Mixed Methods Study.中国医疗保险信息系统:混合方法研究
JMIR Med Inform. 2020 Sep 1;8(9):e18780. doi: 10.2196/18780.
10
Estimated annual prevalence, medical service utilization and direct costs of lung cancer in urban China.中国城市肺癌的年患病率、医疗服务利用情况及直接医疗费用估计。
Cancer Med. 2021 Apr;10(8):2914-2923. doi: 10.1002/cam4.3845. Epub 2021 Mar 21.

本文引用的文献

1
Incidence and prevalence of amyotrophic lateral sclerosis in urban China: a national population-based study.中国城市人群肌萎缩侧索硬化症的发病率和患病率:一项全国性基于人群的研究。
J Neurol Neurosurg Psychiatry. 2020 May;91(5):520-525. doi: 10.1136/jnnp-2019-322317. Epub 2020 Mar 5.
2
Prevalence and Incidence of Multiple Myeloma in Urban Area in China: A National Population-Based Analysis.中国城市地区多发性骨髓瘤的患病率和发病率:一项基于全国人口的分析。
Front Oncol. 2020 Jan 24;9:1513. doi: 10.3389/fonc.2019.01513. eCollection 2019.
3
An update on biology, diagnosis and treatment of primary plasma cell leukemia.
原发性浆细胞白血病的生物学、诊断和治疗的最新进展。
Expert Rev Hematol. 2019 Apr;12(4):245-253. doi: 10.1080/17474086.2019.1598258. Epub 2019 Apr 12.
4
Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis.全球活动性结核病患者中的糖尿病患病率:来自 230 万例结核病患者数据的系统评价和荟萃分析。
Lancet Glob Health. 2019 Apr;7(4):e448-e460. doi: 10.1016/S2214-109X(18)30487-X. Epub 2019 Feb 25.
5
Plasma Cell Leukemia: Definition, Presentation, and Treatment.浆细胞白血病:定义、表现和治疗。
Curr Oncol Rep. 2019 Jan 28;21(1):8. doi: 10.1007/s11912-019-0754-x.
6
Social Media Landscape of the Tertiary Referral Hospitals in China: Observational Descriptive Study.中国三级转诊医院的社交媒体格局:观察性描述性研究。
J Med Internet Res. 2018 Aug 9;20(8):e249. doi: 10.2196/jmir.9607.
7
Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016.多发性骨髓瘤全球负担:2016 年全球疾病负担研究的系统分析。
JAMA Oncol. 2018 Sep 1;4(9):1221-1227. doi: 10.1001/jamaoncol.2018.2128.
8
Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group.新型药物时代下原发性浆细胞白血病预后和结局的真实世界数据:希腊骨髓瘤研究组的一项多中心全国性研究。
Blood Cancer J. 2018 Mar 9;8(3):31. doi: 10.1038/s41408-018-0059-6.
9
Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register.孤立性浆细胞瘤和浆细胞白血病的发病情况、特征和结局。来自瑞典骨髓瘤登记处的基于人群的数据。
Eur J Haematol. 2017 Sep;99(3):216-222. doi: 10.1111/ejh.12907. Epub 2017 Jun 28.
10
Primary Plasma Cell Leukemia: Identity Card 2016.原发性浆细胞白血病:2016年身份卡
Curr Treat Options Oncol. 2016 Apr;17(4):19. doi: 10.1007/s11864-016-0392-6.